✦ LIBER ✦

Clobetasol Propionate Cream Versus Halcinonide Cream in Psoriasis

✍ Scribed by Charles N. Ellis; Eugene J. Van Scott

Book ID: 110875529
Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 763 KB
Volume: 25
Category: Article
ISSN: 0011-9059
DOI: 10.1111/j.1365-4362.1986.tb02261.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clobetasol Propionate Versus Fluocinonid

Clobetasol Propionate Versus Fluocinonide Creams in Psoriasis and Eczema

✍ Brian Jecasothy; Coleman Jacobson; Norman Levine; Larry Millikan; Elise Olsen; S 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Clobetasol Propionate Versus Fluocinonid

Clobetasol Propionate Versus Fluocinonide Creams in Psoriasis and Eczema

✍ Brian Jegasothy; Coleman Jacobson; Norman Levine; Larry Millikan; Elise Olsen; S 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Clinical experience with 0.05% clobetaso

Clinical experience with 0.05% clobetasol propionate creams

✍ Richards, RobertN. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Evaluation of Topical Application of Clo

Evaluation of Topical Application of Clobetasol 17-Propionate from Various Cream Bases

✍ Fang, Jia-You; Shen, Kun-Long; Huang, Yaw-Bin; Wu, Pao-Chu; Tsai, Yi-Hung 📂 Article 📅 1999 🏛 Informa plc 🌐 English ⚖ 127 KB

Comparison of clobetasol propionate crea

Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis

✍ S. Khandpur; V. K. Sharma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

0.25% Prednicarbate cream and the corres

0.25% Prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream

✍ H. C. Korting; D. Vieluf; M. Kerscher 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 301 KB

The atrophogenic potential of medium-potent topical glucocorticoids is still controversial. In a double-blind controlled trial 24 healthy volunteers either applied 0.25% prednicarbate cream or the corresponding vehicle to one and 0.1% betamethasone-17-valerate cream or 0.05% clobetasol-17-propionate